Focused Ultrasound Therapy
Focused ultrasound is an early-stage, noninvasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with post-traumatic stress disorder (PTSD). This novel technology focuses beams of ultrasound energy precisely and accurately on targets deep in the body without damaging surrounding normal tissue.
How it Works
Where the beams converge, focused ultrasound produces neuromodulation, or alterations in the neural responsiveness of target tissues. By altering the responsiveness of the tissues, the impacts on the various symptoms of PTSD are being evaluated.
The primary options for treatment of PTSD include therapy and medication.
For certain patients, focused ultrasound could provide a noninvasive and more effective alternative to conventional care. While significant work has been accomplished, there is still much to be done before this technology will be widely available.
Focused ultrasound is a noninvasive, so it does not carry added concerns like surgical wound healing or infection. It can reach the desired target without damaging surrounding tissue, and it can also be repeated, if necessary.
There is a clinical trial treating a depression that also includes treatment of PTSD in Providence, RI.
There is a clinical trial treating a variety of psychiatric disorders, including PTSD, in Austin, TX.
There is a clinical trial treating a variety of psychiatric disorders, including PTSD, in Los Angeles, CA.
See a full list of PTSD clinical trials >
Regulatory Approval and Reimbursement
Focused ultrasound treatment for PTSD is not yet approved by regulatory bodies or covered by medical insurance companies.
No publications are currently available on PTSD.